The introduction to Nivolumab (Opdivo®) Part. 2. Nivolumab is recommended for the treatment of a variety of malignancies in children aged 12 years and older.Common Pediatric Usage and Dosage of Nivolumab:Recommended dose of nivolumab monotherapy:
Indications
Dosage
Duration
Unresectable or metastatic melanoma
For pediatric patients...
